Zentiva Expands European Footprint with Aboca Brand Acquisition

Zentiva, a European leader in the development and supply of affordable medicines, has announced the acquisition of five heritage brands from Aboca, an Italian herbal supplement company. This move aims to bolster Zentiva's presence in the Consumer Healthcare (CHC) market, particularly in the rapidly growing categories of respiratory, circulatory, and calm & sleep solutions. The acquisition, effective from June 30, 2025, includes brands such as Propol2 EMF, Ruscoven, and Serenil, integrating their natural-based solutions into Zentiva's portfolio. This strategic expansion targets key European markets including Italy, Spain, and France while extending to Portugal, Poland, Romania, and Greece. Zentiva has a robust strategy to leverage this acquisition to boost its leadership in natural self-care, aligning with the increasing consumer demand for sustainable products. The acquisition is part of Zentiva’s broader goal to provide high-quality medical solutions to over 100 million people across more than 30 countries, supporting its vision for sustainable growth and long-term market leadership.